Want to see GB:APTA full AI Analyst Report?
APTA Stock Chart & Stats
0.80 p
-0.01 p(-2.86%)
At close: 4:00 PM EST
0.80 p
-0.01 p(-2.86%)
Day’s Range― - ―
52-Week Range0.32 p - 1.57 p
Previous CloseN/A
Volume3.91M
Average Volume (3M)15.29M
Market Cap
£16.41M
Enterprise Value13.44M
Total Cash (Recent Filing)£1.53M
Total Debt (Recent Filing)£333.00K
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Oct 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,455,144,000
10 Day Avg. Volume14,821,052
30 Day Avg. Volume15,285,032
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)5.32
Price to Sales (P/S)6.11
P/FCF Ratio-3.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Leverage ManagementImproved debt-to-equity indicates structurally lower financial risk and interest burden, enhancing flexibility to fund R&D or partnerships. Better leverage management lengthens runway and reduces refinancing pressure, supporting a stronger capital structure if operating trends recover.
Proprietary Aptamer Platform And ServicesAptamer Group’s proprietary discovery platform and services create technical differentiation and partner lock-in potential. The combination of platform IP plus service revenue offers durable commercial pathways into diagnostics, research reagents, and potential therapeutics beyond one-off product sales.
Slight Free Cash Flow ImprovementA modest improvement in free cash flow growth signals early progress on cash discipline or cost control. If sustained, this structural trend can extend runway, reduce reliance on dilutive funding and provide a foundation for reinvesting in core platform development and customer growth.
Bears Say
Severe Revenue CollapseA near-total revenue collapse dramatically reduces scale, limits ability to fund R&D and commercial activities, and erodes partner confidence. Without durable new contracts or a clear revenue recovery plan, rebuilding scale will be slow and materially constrain long-term competitiveness.
Persistent Losses And Weak MarginsOngoing negative net profit and EBIT margins indicate the business is not yet earning returns on operations. Structural unprofitability reduces reinvestment capacity, makes long-term planning dependent on external funding, and weakens incentives for strategic partnerships or talent retention.
Negative Operating Cash Flow And Cash BurnContinued negative operating and free cash flows point to structural cash burn; this forces reliance on financing or dilution and constrains strategic investment. Even with slight FCF improvement, persistent cash outflows threaten runway absent sustained margin or revenue recovery.
Aptamer Group Plc News
APTA FAQ
What was Aptamer Group Plc’s price range in the past 12 months?
Aptamer Group Plc lowest share price was 0.32 p and its highest was 1.57 p in the past 12 months.
What is Aptamer Group Plc’s market cap?
Aptamer Group Plc’s market cap is £16.41M.
When is Aptamer Group Plc’s upcoming earnings report date?
Aptamer Group Plc’s upcoming earnings report date is Oct 20, 2026 which is in 93 days.
How were Aptamer Group Plc’s earnings last quarter?
Aptamer Group Plc released its earnings results on Mar 25, 2026. The company reported 0 p earnings per share for the quarter, the consensus estimate of N/A by 0 p.
Is Aptamer Group Plc overvalued?
According to Wall Street analysts Aptamer Group Plc’s price is currently Overvalued.
Does Aptamer Group Plc pay dividends?
Aptamer Group Plc does not currently pay dividends.
What is Aptamer Group Plc’s EPS estimate?
Aptamer Group Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptamer Group Plc have?
Aptamer Group Plc has 3,455,144,000 shares outstanding.
What happened to Aptamer Group Plc’s price movement after its last earnings report?
Aptamer Group Plc reported an EPS of 0 p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Aptamer Group Plc?
Currently, no hedge funds are holding shares in GB:APTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aptamer Group Plc
Aptamer Group plc, an international company headquartered in York, United Kingdom, specializes in providing advanced binders for applications spanning research, diagnostics, and therapeutics. Their innovative binder technology is engineered to resolve challenges often associated with traditional molecular tools, such as antibodies, offering crucial solutions to bioprocessing, diagnostic, and pharmaceutical scientists. Established in 2014, the company primarily serves pharmaceutical corporations, diagnostic development firms, and various research institutes.
Technical Analysis
Avacta Group plc
―
Bioventix
―
Oxford BioDynamics
―
Fusion Antibodies Plc
―
Arecor Therapeutics PLC
―